Structure-activity relationship studies of functionalized aromatic peptidomimetics as neurolysin activators
- 12 March 2022
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 64, 128669
Abstract
No abstract availableKeywords
Funding Information
- University of Nebraska Medical Center
- Texas Tech University
- National Institutes of Health (R01NS106879)
This publication has 17 references indexed in Scilit:
- The role of peptidase neurolysin in neuroprotection and neural repair after strokeNeural Regeneration Research, 2021
- Peptidase neurolysin is an endogenous cerebroprotective mechanism in acute neurodegenerative disordersMedical Hypotheses, 2019
- Lipophilic Efficiency as an Important Metric in Drug DesignJournal of Medicinal Chemistry, 2018
- Selecting Good ‘Drug-Like’ Properties to Optimize Small Molecule Blood-Brain Barrier PenetrationCurrent Medicinal Chemistry, 2016
- Heart Disease and Stroke Statistics—2016 UpdateCirculation, 2016
- Thrombolytics in Acute Ischaemic Stroke: Historical Perspective and Future OpportunitiesCerebrovascular Diseases, 2013
- Recombinant Tissue Plasminogen Activator for the Treatment of Acute Ischemic StrokeBaylor University Medical Center Proceedings, 2011
- Intravenous Thrombolytics for Ischemic StrokeNeurotherapeutics, 2011
- Association of the Novel Non-AT1, Non-AT2 Angiotensin Binding Site with Neuronal Cell DeathThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike PropertiesACS Chemical Neuroscience, 2010